Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Follows people with lupus nephritis to track long-term kidney and survival outcomes

Observes people with lupus-related kidney disease over time to study long-term kidney health and survival.

Plain-language title generated from the registry record
Registry title: High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)

Key facts

Where
Guangzhou, ChinaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with lupus nephritis confirmed by kidney biopsy at one hospital in Guangzhou. They will be followed over time to see how long their kidneys work and how long they live.

Age
14 years and older
Sex
All sexes can join
Disease stage
Lupus nephritis proven by kidney biopsy at The First Affiliated Hospital of Sun Yat-sen University

Main reasons for not taking part

  • Younger than 14 years
  • Refused to give written consent

Read by machine on 9 November 2026.

Where in China

  • the First Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
First Affiliated Hospital, Sun Yat-Sen University
Trial code
NCT06682507
Record updated
12 November 2024
Original description
The goal of this observational study is to learn about the long-term renal and patient's survival of lupus nephritis (LN) patients in China. The main question it aims to answer is:Read full original descriptionShow less

High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)

The goal of this observational study is to learn about the long-term renal and patient's survival of lupus nephritis (LN) patients in China. The main question it aims to answer is:

Does the renal and patient's survival improved in the long term period? Participants who had renal biopsy proven lupus nephritis in one hospital will be followed up.

Inclusion: Patients who had biopsy proven lupus nephritis in The First Affiliated Hospital of Sun Yat-sen University.

Exclusion: less than 14 years old; refused to give written consent.

ClinicalTrials.gov NCT06682507